A Japanese adult case of guanidinoacetate methyltransferase deficiency

Tomoyuki Akiyama, Hitoshi Osaka, Hiroko Shimbo, Tomoshi Nakajiri, Katsuhiro Kobayashi, Makio Oka, Fumika Endoh, Harumi Yoshinaga

Research output: Contribution to journalArticle

Abstract

Guanidinoacetate methyltransferase (GAMT) deficiency is a rare disorder of creatine synthesis resulting in cerebral creatine depletion. We present a 38-year-old patient, the first Japanese case of GAMT deficiency. Developmental delay started after a few months of age with a marked delay in language, which resulted in severe intellectual deficit. She showed hyperactivity and trichotillomania from childhood. Epileptic seizures appeared at 18 months and she had multiple types of seizures including epileptic spasms, brief tonic seizures, atypical absences, complex partial seizures with secondary generalization, and "drop" seizures. They have been refractory to multiple antiepileptic drugs. Although there have been no involuntary movements, magnetic resonance imaging revealed T2 hyperintense lesions in bilateral globus pallidi. Motor regression started around 30 years of age and the patient is now able to walk for only short periods. Very low serum creatinine levels measured by enzymatic method raised a suspicion of GAMT deficiency, which was confirmed by proton magnetic resonance spectroscopy and urinary guanidinoacetate assay. GAMT gene analysis revealed that the patient is a compound heterozygote of c.578A>G, p.Gln193Arg and splice site mutation, c.391G>C, p.Gly131Arg, neither of which have been reported in the literature. We also identified two aberrant splice products from the patient's cDNA analysis. The patient was recently started on supplementation of high-dose creatine and ornithine, the effects of which are currently under evaluation. Although rare, patients with developmental delay, epilepsy, behavioral problems, and movement disorders should be vigorously screened for GAMT deficiency, as it is a treatable disorder.

Original languageEnglish
Pages (from-to)65-69
Number of pages5
JournalJIMD Rep
Volume12
DOIs
Publication statusPublished - 2014

Fingerprint

Creatine
Epilepsy
Seizures
Guanidinoacetate N-Methyltransferase
Trichotillomania
Language Development Disorders
Globus Pallidus
Ornithine
Dyskinesias
Movement Disorders
Spasm
Heterozygote
Anticonvulsants
Guanidinoacetate methyltransferase deficiency
Creatinine
Complementary DNA
Magnetic Resonance Imaging
Mutation
Serum
Genes

Cite this

A Japanese adult case of guanidinoacetate methyltransferase deficiency. / Akiyama, Tomoyuki; Osaka, Hitoshi; Shimbo, Hiroko; Nakajiri, Tomoshi; Kobayashi, Katsuhiro; Oka, Makio; Endoh, Fumika; Yoshinaga, Harumi.

In: JIMD Rep, Vol. 12, 2014, p. 65-69.

Research output: Contribution to journalArticle

Akiyama, Tomoyuki ; Osaka, Hitoshi ; Shimbo, Hiroko ; Nakajiri, Tomoshi ; Kobayashi, Katsuhiro ; Oka, Makio ; Endoh, Fumika ; Yoshinaga, Harumi. / A Japanese adult case of guanidinoacetate methyltransferase deficiency. In: JIMD Rep. 2014 ; Vol. 12. pp. 65-69.
@article{8b76eda782d040d8aab19b7b1c422a7c,
title = "A Japanese adult case of guanidinoacetate methyltransferase deficiency",
abstract = "Guanidinoacetate methyltransferase (GAMT) deficiency is a rare disorder of creatine synthesis resulting in cerebral creatine depletion. We present a 38-year-old patient, the first Japanese case of GAMT deficiency. Developmental delay started after a few months of age with a marked delay in language, which resulted in severe intellectual deficit. She showed hyperactivity and trichotillomania from childhood. Epileptic seizures appeared at 18 months and she had multiple types of seizures including epileptic spasms, brief tonic seizures, atypical absences, complex partial seizures with secondary generalization, and {"}drop{"} seizures. They have been refractory to multiple antiepileptic drugs. Although there have been no involuntary movements, magnetic resonance imaging revealed T2 hyperintense lesions in bilateral globus pallidi. Motor regression started around 30 years of age and the patient is now able to walk for only short periods. Very low serum creatinine levels measured by enzymatic method raised a suspicion of GAMT deficiency, which was confirmed by proton magnetic resonance spectroscopy and urinary guanidinoacetate assay. GAMT gene analysis revealed that the patient is a compound heterozygote of c.578A>G, p.Gln193Arg and splice site mutation, c.391G>C, p.Gly131Arg, neither of which have been reported in the literature. We also identified two aberrant splice products from the patient's cDNA analysis. The patient was recently started on supplementation of high-dose creatine and ornithine, the effects of which are currently under evaluation. Although rare, patients with developmental delay, epilepsy, behavioral problems, and movement disorders should be vigorously screened for GAMT deficiency, as it is a treatable disorder.",
author = "Tomoyuki Akiyama and Hitoshi Osaka and Hiroko Shimbo and Tomoshi Nakajiri and Katsuhiro Kobayashi and Makio Oka and Fumika Endoh and Harumi Yoshinaga",
year = "2014",
doi = "10.1007/8904_2013_245",
language = "English",
volume = "12",
pages = "65--69",
journal = "JIMD Reports",
issn = "2192-8304",
publisher = "Springer Berlin",

}

TY - JOUR

T1 - A Japanese adult case of guanidinoacetate methyltransferase deficiency

AU - Akiyama, Tomoyuki

AU - Osaka, Hitoshi

AU - Shimbo, Hiroko

AU - Nakajiri, Tomoshi

AU - Kobayashi, Katsuhiro

AU - Oka, Makio

AU - Endoh, Fumika

AU - Yoshinaga, Harumi

PY - 2014

Y1 - 2014

N2 - Guanidinoacetate methyltransferase (GAMT) deficiency is a rare disorder of creatine synthesis resulting in cerebral creatine depletion. We present a 38-year-old patient, the first Japanese case of GAMT deficiency. Developmental delay started after a few months of age with a marked delay in language, which resulted in severe intellectual deficit. She showed hyperactivity and trichotillomania from childhood. Epileptic seizures appeared at 18 months and she had multiple types of seizures including epileptic spasms, brief tonic seizures, atypical absences, complex partial seizures with secondary generalization, and "drop" seizures. They have been refractory to multiple antiepileptic drugs. Although there have been no involuntary movements, magnetic resonance imaging revealed T2 hyperintense lesions in bilateral globus pallidi. Motor regression started around 30 years of age and the patient is now able to walk for only short periods. Very low serum creatinine levels measured by enzymatic method raised a suspicion of GAMT deficiency, which was confirmed by proton magnetic resonance spectroscopy and urinary guanidinoacetate assay. GAMT gene analysis revealed that the patient is a compound heterozygote of c.578A>G, p.Gln193Arg and splice site mutation, c.391G>C, p.Gly131Arg, neither of which have been reported in the literature. We also identified two aberrant splice products from the patient's cDNA analysis. The patient was recently started on supplementation of high-dose creatine and ornithine, the effects of which are currently under evaluation. Although rare, patients with developmental delay, epilepsy, behavioral problems, and movement disorders should be vigorously screened for GAMT deficiency, as it is a treatable disorder.

AB - Guanidinoacetate methyltransferase (GAMT) deficiency is a rare disorder of creatine synthesis resulting in cerebral creatine depletion. We present a 38-year-old patient, the first Japanese case of GAMT deficiency. Developmental delay started after a few months of age with a marked delay in language, which resulted in severe intellectual deficit. She showed hyperactivity and trichotillomania from childhood. Epileptic seizures appeared at 18 months and she had multiple types of seizures including epileptic spasms, brief tonic seizures, atypical absences, complex partial seizures with secondary generalization, and "drop" seizures. They have been refractory to multiple antiepileptic drugs. Although there have been no involuntary movements, magnetic resonance imaging revealed T2 hyperintense lesions in bilateral globus pallidi. Motor regression started around 30 years of age and the patient is now able to walk for only short periods. Very low serum creatinine levels measured by enzymatic method raised a suspicion of GAMT deficiency, which was confirmed by proton magnetic resonance spectroscopy and urinary guanidinoacetate assay. GAMT gene analysis revealed that the patient is a compound heterozygote of c.578A>G, p.Gln193Arg and splice site mutation, c.391G>C, p.Gly131Arg, neither of which have been reported in the literature. We also identified two aberrant splice products from the patient's cDNA analysis. The patient was recently started on supplementation of high-dose creatine and ornithine, the effects of which are currently under evaluation. Although rare, patients with developmental delay, epilepsy, behavioral problems, and movement disorders should be vigorously screened for GAMT deficiency, as it is a treatable disorder.

U2 - 10.1007/8904_2013_245

DO - 10.1007/8904_2013_245

M3 - Article

C2 - 23846910

VL - 12

SP - 65

EP - 69

JO - JIMD Reports

JF - JIMD Reports

SN - 2192-8304

ER -